Faculty Advisor(s)

Elaine Halesey



Download Full Text (419 KB)


Radiation therapy is an ever-changing field, making it easier and safer to treat a broader range of cancers. With the advancement of the CyberKnife System, we can now investigate how effective stereotactic body radiation therapy (SBRT) treatments are in terms of treating hepatocellular carcinoma (HCC) patients. HCC is the most common liver cancer as well as one of the most prominent cancer-related deaths in the world. Several studies indicated that, previously, treating HCC with ionizing radiation was not an effective option due to the liver’s sensitivity to radiation, among other factors. After conducting research and examining nine different sources, there seems to be a common theme with patients who have started treatment with CyberKnife SBRT. Studies show a high percentage of in-field recurrence free rates after one and two years, as well as encouraging overall survival rates. In some studies, results also showed higher local control rates and lower toxicity reaction rates. CyberKnife SBRT can be used to treat patients

Publication Date


Document Type



Medical Imaging


CyberKnife, radiation therapy, hepatocellular carcinoma, liver cancer treatment


Medicine and Health Sciences

The Use of CyberKnife Stereotactic Body Radiation Therapy in Treating Hepatocellular Carcinoma



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.